2021
DOI: 10.1101/2021.04.26.21254132
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Genetic analysis of lung cancer reveals novel susceptibility loci and germline impact on somatic mutation burden

Abstract: Large international efforts are describing how germline variants influence susceptibility to lung cancer. We have undertaken a genome-wide association by proxy (GWAx) study of lung cancer in 48,843 proxy “cases” with a parent/sibling with lung cancer to 195,387 proxy controls without a family history of any cancer from the UK Biobank and meta-analysed the results with previously described GWA study results. 21 loci achieved genome-wide statistical significance, including 8 novel loci including expression quant… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
2

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 58 publications
0
8
0
Order By: Relevance
“…Pulmonary carcinogenesis is a complex process, with interactions that modulate the potential risks for the disease [ 7 , 31 ]. Many studies have described how germline variants influence susceptibility to lung cancer, including those linked to smoking [ 32 , 33 , 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…Pulmonary carcinogenesis is a complex process, with interactions that modulate the potential risks for the disease [ 7 , 31 ]. Many studies have described how germline variants influence susceptibility to lung cancer, including those linked to smoking [ 32 , 33 , 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…With the advent of early detection by LDCT screening, a strong focus has been placed on lung cancer. A wide array of circulating biomarkers have been proposed, including germline gene variants, 27,28 microRNA, 29,30 epigenetic markers, 31 autoantibodies, 32 protein markers, 33,34 and circulating tumor DNA. 35 However, few have been independently validated, and none are widely used in screening.…”
Section: Discussionmentioning
confidence: 99%
“…Analyses of molecular phenotypes were performed using 343 lung adenocarcinoma samples of European ancestry from The Cancer Genome Atlas (TGCA) cohort with both germline and RNA-sequencing data available. Genotyping and imputation of germline variants have been described elsewhere [21]. The total somatic mutation burden of TCGA samples were obtained from Ellrott et al, 2018 [22] and DNA mutational signatures were extracted and attributed, as previously described [21].…”
Section: Datamentioning
confidence: 99%
“…Genotyping and imputation of germline variants have been described elsewhere [21]. The total somatic mutation burden of TCGA samples were obtained from Ellrott et al, 2018 [22] and DNA mutational signatures were extracted and attributed, as previously described [21]. RNA-sequencing data were obtained from TCGA data portal using TCGAbiolinks package in R (version 2.22.3) [23].…”
Section: Datamentioning
confidence: 99%
See 1 more Smart Citation